CANZIT MX CREAM is a combination of Clobetasol, Miconazole and Neomycin which belongs to the group of medicines called Corticosteroids, Antifungals and Antibiotics. It is used to treat resistant dermatoses (skin infections) with secondary bacterial or fungal infection.
CANZIT MX CREAM is not recommended for use in patients with rosacea, acne vulgaris, perioral dermatitis, perianal and genital pruritus, viral infections (ex. herpes simplex, chickenpox) and perforated eardrum. Contact your doctor before applying.
CANZIT MX CREAM should be used with caution in patients with liver or kidney disease. Contact your doctor before applying.
CANZIT MX CREAM is generally not recommended for use in pregnancy unless considered clearly necessary. CANZIT MX CREAM should be used with caution in breastfeeding women as it is not known whether it may pass through the breast milk. Contact your doctor before applying.
CANZIT MX CREAM is not recommended for use in children under 2 years of age and should be used with caution in children above 2 years of age. Contact your doctor before applying.
Dosage adjustment is not required for CANZIT MX CREAM in the geriatric population. However, greater sensitivity of some older individuals cannot be ruled out. Contact your doctor before applying.
The most common side effects of this medicine are skin rash, itching, redness, burning sensation and contact dermatitis. Contact your physician if any of the symptoms worsen.
CANZIT MX CREAM helps to treat infection, where Clobetasol have anti-inflammatory, antipruritic, and vasoconstrictive properties, which blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen, and itchy. Miconazole is an antifungal which stops the growth of fungi while Neomycin is an antibiotic which stops the growth of bacteria in the skin.
Apply CANZIT MX CREAM as directed by your physician. It is for external use only. Wash your hands with soap and water and apply a thin layer of the medicine to the affected area of the skin and rub it gently. Avoid contact with eyes, face, groin or in the skin folds.
Stop applying CANZIT MX CREAM and contact your physician immediately if you experience any of the following side effects:
Itchy skin:
Avoid hot showers because hot water can irritate the skin. Do not scratch the affected area. Use sunscreen and protective clothing when outdoors. Regularly use unscented moisturizers to soothe and hydrate the affected area. Contact your doctor if itching worsens.
CANZIT MX CREAM is generally not recommended for use in pregnancy unless considered clearly necessary. Contact your doctor before applying.
CANZIT MX CREAM should be used with caution in breastfeeding women as it is not known whether it may pass through the breast milk. Contact your doctor before applying.
CANZIT MX CREAM should be used with caution in patients with kidney disease. Contact your doctor before applying.
CANZIT MX CREAM should be used with caution in patients with liver disease. Contact your doctor before applying.
CANZIT MX CREAM is not recommended for use in patients allergic to clobetasol, miconazole, neomycin, or to other ingredients of this medicine.
CANZIT MX CREAM is not recommended for use if you have:
Use in pediatrics:
CANZIT MX CREAM is not recommended for use in children under 2 years of age and should be used with caution in children above 2 years of age. Contact your doctor before applying.
Use in geriatrics:
Dosage adjustment is not required for CANZIT MX CREAM in the geriatric population. However, greater sensitivity of some older individuals cannot be ruled out. Contact your doctor before applying.
A. Drug-Drug interactions:
Tell your doctor if you are taking,
Overdosage:
If you or anyone else accidentally use too much of CANZIT MX CREAM, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage are skin irritation, Hypothalamic-pituitary adrenal (HPA) axis suppression, cushingoid features (Ex. moon face, central obesity), ear damage and kidney damage may occur.
Drug | : | Clobetasol, Miconazole, Neomycin |
Pharmacological Category | : | Corticosteroids, Antifungals, Antibiotics |
Therapeutic Indication | : | Skin infections |
Dosage Forms | : | Cream, Lotion, Ointment |
Q: What are the possible side effects of applying CANZIT MX CREAM?
A: The most common side effects of this medicine are skin rash, urticaria, itching, redness, burning sensation and contact dermatitis. Contact your physician if any of the symptoms worsen.
Q: Can I use CANZIT MX CREAM in children?
A: CANZIT MX CREAM is not recommended for use in children under 2 years of age and should be used with caution in children above 2 years of age. Contact your doctor before applying.
Q: For what conditions CANZIT MX CREAM is used?
A: CANZIT MX CREAM is used to treat resistant dermatoses (skin infections) with secondary bacterial or fungal infection.
Q: Does CANZIT MX CREAM cause itching on the skin?
A: Yes, CANZIT MX CREAM may cause skin itching at the site of application as a temporary side effect. However, if the itching persists or worsens, consult your doctor for advice.
Q: Can I stop using CANZIT MX CREAM when my symptoms are relieved?
A: No, do not stop using CANZIT MX CREAM and complete the full course of treatment, even if you feel better. Your symptoms may improve before the infection is completely cured.
Q: Who should not use CANZIT MX CREAM?
A: CANZIT MX CREAM is not recommended for use in patients with rosacea, acne vulgaris, perioral dermatitis, perianal and genital pruritus, viral infections (ex. herpes simplex, chickenpox), perforated eardrum. Contact your doctor before applying.
1. K.D. Tripathi. Drugs acting on the skin and mucous membrane, Antifungal Drugs & Aminoglycoside Antibiotics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 895, 792, 750.
2. Bethesda (MD). Clobetasol. National Institute of Health. NLM. National Centre for Biotechnology Information. PubChem Compound Summary. 2004. [Accessed on 17th June 2022] https://pubchem.ncbi.nlm.nih.gov/compound/5311051
3. Bethesda (MD). Miconazole. National Institute of Health. NLM. National Centre for Biotechnology Information. PubChem Compound Summary. 2004. [Accessed on 17th June 2022] https://pubchem.ncbi.nlm.nih.gov/compound/4189
4. Bethesda (MD). Neomycin. National Institute of Health. NLM. National Centre for Biotechnology Information. PubChem Compound Summary. 2004. [Accessed on 17th June 2022] https://pubchem.ncbi.nlm.nih.gov/compound/Neomycin
5. Blue Cross labs. Clobetasol, Miconazole and Neomycin. [Revised on May 2020] [Accessed on 24th June 2022] https://www.bluecrosslabs.com/img/sections/SONADERM-NM-CREAM.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.